← FDA DRUG APPROVALS

FDA ANDA · ANDA216715

PREDNISOLONE SODIUM PHOSPHATE

Sponsor: AMNEAL

APPLICATION
ANDA216715
TYPE
ANDA
ORIGINAL APPROVAL
2022-10-25
LATEST ACTION
2025-07-23
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

PREDNISOLONE SODIUM PHOSPHATEPrescription
PREDNISOLONE SODIUM PHOSPHATE EQ 15MG BASE/5ML · SOLUTION · ORAL

Approval history

2025-07-23Labeling · Supplement 3 · standardAP
2022-10-25UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →